Works about BIOLOGICALS
Results: 2606
Dual Therapy in Inflammatory Bowel Disease.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 222, doi. 10.3390/biom15020222
- By:
- Publication type:
- Article
A Comprehensive Review of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 300, doi. 10.3390/biomedicines13020300
- By:
- Publication type:
- Article
THE PREVALENCE OF REACTIVE SCREENING IN WHOLE BLOOD DONATION IN HUSM.
- Published in:
- Malaysian Journal of Medical Sciences, 2006, v. 13, p. 133
- By:
- Publication type:
- Article
Biological Activities of Korean Citrus obovoides and Citrus natsudaidai Essential Oils against Acne-Inducing Bacteria.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2008, v. 72, n. 10, p. 2507, doi. 10.1271/bbb.70388
- By:
- Publication type:
- Article
Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 16
- By:
- Publication type:
- Article
Building Biologics Contract-Manufacturing Capacity.
- Published in:
- Innovation, 2004, v. 4, n. 3, p. 44
- By:
- Publication type:
- Article
The Future of Biologics Manufacturing in Singapore.
- Published in:
- Innovation, 2004, v. 4, n. 3, p. 43
- By:
- Publication type:
- Article
A Review of Sinus Floor Elevation Techniques: Lateral Window, Transcrestal, Graft Materials, and Biologics.
- Published in:
- Compendium of Continuing Education in Dentistry (15488578), 2024, v. 45, n. 8, p. 418
- By:
- Publication type:
- Article
Immediate Implant Solution to Improve Long-Term Esthetics, Enhance Patient Satisfaction.
- Published in:
- Compendium of Continuing Education in Dentistry (15488578), 2021, v. 42, n. 4, p. 1
- By:
- Publication type:
- Article
Periodontal Tissue Bioengineering: Is the Future Now?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multicomponent Peptide Stapling as a Diversity‐Driven Tool for the Development of Inhibitors of Protein–Protein Interactions.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 13, p. 5273, doi. 10.1002/ange.201916257
- By:
- Publication type:
- Article
Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 4, p. 341, doi. 10.1007/s10157-021-02160-2
- By:
- Publication type:
- Article
Optimizing transcardial perfusion of small molecules and biologics for brain penetration and biodistribution studies in rodents.
- Published in:
- Biopharmaceutics & Drug Disposition, 2023, v. 44, n. 1, p. 71, doi. 10.1002/bdd.2317
- By:
- Publication type:
- Article
Infliximab rather than tocilizumab for HLA-B52-positive Takayasu arteritis?
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 12, p. 4009, doi. 10.1007/s10067-024-07196-9
- By:
- Publication type:
- Article
Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 12, p. 3625, doi. 10.1007/s10067-024-07161-6
- By:
- Publication type:
- Article
Safety and efficacy of biologics in childhood systemic lupus erythematosus: a critical systematic review.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 863, doi. 10.1007/s10067-023-06833-z
- By:
- Publication type:
- Article
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 657, doi. 10.1007/s10067-023-06836-w
- By:
- Publication type:
- Article
Biologic drugs in the treatment of juvenile dermatomyositis: a literature review.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 591, doi. 10.1007/s10067-023-06740-3
- By:
- Publication type:
- Article
Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 12, p. 3251, doi. 10.1007/s10067-023-06724-3
- By:
- Publication type:
- Article
What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 8, p. 2173, doi. 10.1007/s10067-023-06616-6
- By:
- Publication type:
- Article
Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 5, p. 1275, doi. 10.1007/s10067-023-06531-w
- By:
- Publication type:
- Article
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 12, p. 3615, doi. 10.1007/s10067-022-06307-8
- By:
- Publication type:
- Article
Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 5, p. 1583, doi. 10.1007/s10067-022-06106-1
- By:
- Publication type:
- Article
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 5, p. 1439, doi. 10.1007/s10067-021-06012-y
- By:
- Publication type:
- Article
Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 12, p. 4869, doi. 10.1007/s10067-021-05744-1
- By:
- Publication type:
- Article
Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 11, p. 4369, doi. 10.1007/s10067-021-05933-y
- By:
- Publication type:
- Article
Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 9, p. 3499, doi. 10.1007/s10067-021-05622-w
- By:
- Publication type:
- Article
Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3105, doi. 10.1007/s10067-021-05613-x
- By:
- Publication type:
- Article
Accessibility to biologics and its impact on disease activity and quality of life in patients with rheumatoid arthritis in Kuwait.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 5, p. 1759, doi. 10.1007/s10067-020-05444-2
- By:
- Publication type:
- Article
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 5, p. 1871, doi. 10.1007/s10067-020-05433-5
- By:
- Publication type:
- Article
Biologics in systemic autoimmune diseases during COVID-19 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 9, p. 2563, doi. 10.1007/s10067-020-05015-5
- By:
- Publication type:
- Article
Risk factors, including different biologics, associated with depression and anxiety in patients with rheumatoid arthritis: a cross-sectional observational study.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 3, p. 737, doi. 10.1007/s10067-019-04820-x
- By:
- Publication type:
- Article
The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 11, p. 3081, doi. 10.1007/s10067-019-04649-4
- By:
- Publication type:
- Article
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 8, p. 2129, doi. 10.1007/s10067-019-04516-2
- By:
- Publication type:
- Article
Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 3, p. 727, doi. 10.1007/s10067-018-4340-7
- By:
- Publication type:
- Article
Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 12, p. 3263, doi. 10.1007/s10067-018-4297-6
- By:
- Publication type:
- Article
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 6, p. 1449, doi. 10.1007/s10067-018-4038-x
- By:
- Publication type:
- Article
Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan.
- Published in:
- Surgery Today, 2016, v. 46, n. 8, p. 930, doi. 10.1007/s00595-015-1259-3
- By:
- Publication type:
- Article
Improved fusion tag cleavage strategies in the downstream processing of self-assembling virus-like particle vaccines.
- Published in:
- Food & Bioproducts Processing: Transactions of the Institution of Chemical Engineers Part C, 2014, v. 92, n. 2, p. 143, doi. 10.1016/j.fbp.2013.08.012
- By:
- Publication type:
- Article
Continuous aqueous two-phase systems devices for the recovery of biological products.
- Published in:
- Food & Bioproducts Processing: Transactions of the Institution of Chemical Engineers Part C, 2014, v. 92, n. 2, p. 101, doi. 10.1016/j.fbp.2013.05.006
- By:
- Publication type:
- Article
Current hip cartilage regeneration/repair modalities: a scoping review of biologics and surgery.
- Published in:
- International Orthopaedics, 2021, v. 45, n. 2, p. 319, doi. 10.1007/s00264-020-04789-2
- By:
- Publication type:
- Article
A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015–2020.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03147-1
- By:
- Publication type:
- Article
Equity in the usage of biologics for psoriasis in the working poor.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 4, p. 1029, doi. 10.1007/s00403-022-02410-7
- By:
- Publication type:
- Article
Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide.
- Published in:
- Archives of Dermatological Research, 2022, v. 314, n. 7, p. 687, doi. 10.1007/s00403-021-02273-4
- By:
- Publication type:
- Article
Comparison of physical and mental functioning among moderate-to-severe psoriasis patients on biologic versus oral therapy.
- Published in:
- Archives of Dermatological Research, 2019, v. 311, n. 6, p. 453, doi. 10.1007/s00403-019-01918-9
- By:
- Publication type:
- Article
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
- Published in:
- Archives of Dermatological Research, 2015, v. 307, n. 10, p. 875, doi. 10.1007/s00403-015-1593-8
- By:
- Publication type:
- Article
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients.
- Published in:
- Archives of Dermatological Research, 2007, v. 298, n. 7, p. 309, doi. 10.1007/s00403-006-0707-8
- By:
- Publication type:
- Article
Development of the Conditions for Direct Quantitative Determination of Amino Acids in Biologics by Hydrophilic Interaction HPLC.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 55, n. 6, p. 621, doi. 10.1007/s11094-021-02467-0
- By:
- Publication type:
- Article
Development and Validation of a Gas-Chromatographic Method for Quantitative Determination of Phenol in Biologicals.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 52, n. 5, p. 478, doi. 10.1007/s11094-018-1843-0
- By:
- Publication type:
- Article